Milk matters: Soluble toll-like receptor 2 (sTLR2) in breast milk significantly inhibits HIV-1 infection and inflammation

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Henrick, Bethany M ^a   Nag, Kakon ^a   Yao, Xiao Dan ^a   Drannik, Anna G ^a   Aldrovandi, Grace M ^b   Rosenthal, Kenneth L ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BREAST FEEDING; BREAST MILK; CARBOXY TERMINAL SEQUENCE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN STABILITY; VIRUS INHIBITION; VIRUS TRANSMISSION; WESTERN BLOTTING;

ANTIBODIES; ANTIBODY SPECIFICITY; BACTERIAL PROTEINS; CELL LINE; CYTOKINES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; LIPOPROTEINS; MILK, HUMAN; PEPTIDES; TOLL-LIKE RECEPTOR 2;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84863714569     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040138     Document Type: Article

References (52)

1. Grulee CG, Sanford HN, Schwartz H, (1935) Breast and Artificially Fed Infants. Jour AMA pp. 1-3.
2. Beaudry M, Dufour R, Marcoux S, (1995) Relation between infant feeding and infections during the first six months of life. J Pediatr 126: 191-197.
3. Kramer MS, (2010) "Breast is best": The evidence. Early Hum Dev 86: 729-732 doi:10.1016/j.earlhumdev.2010.08.005.
4. Arifeen S, Black RE, Antelman G, Baqui A, Caulfield L, et al. (2001) Exclusive breastfeeding reduces acute respiratory pp. 1-10 doi:10.1542/peds.108.4.e67.
5. Coovadia HM, Rollins NC, Bland RM, Little K, Coutsoudis A, et al. (2007) Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 369: 1107-1116 doi:10.1016/S0140-6736(07)60283-9.
6. Coutsoudis A, Kuhn L, Pillay K, Coovadia HM, (2002) Exclusive breast-feeding and HIV transmission. AIDS 16: 498-499.
7. Kuhn L, Sinkala M, Kankasa C, Semrau K, Kasonde P, et al. (2007) High uptake of exclusive breastfeeding and reduced early post-natal HIV transmission. PLoS ONE 2: e1363 doi:10.1371/journal.pone.0001363.
8. Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, et al. (2005) Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 19: 699-708.
9. Kazmi SH, Naglik JR, Sweet SP, Evans RW, O'Shea S, et al. (2006) Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids. Clin Vaccine Immunol 13: 1111-1118 doi:10.1128/CDLI.00426-05.
10. Lyimo MA, Howell AL, Balandya E, Eszterhas SK, Connor RI, (2009) Innate factors in human breast milk inhibit cell-free HIV-1 but not cell-associated HIV-1 infection of CD4+ cells. J Acquir Immune Defic Syndr 51: 117-124 doi:10.1097/QAI.0b013e3181a3908d.
11. Salvatori F, Scarlatti G, (2001) HIV type 1 chemokine receptor usage in mother-to-child transmission. AIDS Res Hum Retroviruses 17: 925-935 doi:10.1089/088922201750290041.
12. Matala E, Hahn T, Yedavalli VR, Ahmad N, (2001) Biological characterization of HIV type 1 envelope V3 regions from mothers and infants associated with perinatal transmission. AIDS Res Hum Retroviruses 17: 1725-1735 doi:10.1089/08892220152741423.
13. Ahmad N, (2011) Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells. Life Sci 88: 980-986 doi:10.1016/j.lfs.2010.09.023.
14. Pádua E, Parreira R, Tendeiro R, Nunes B, Castela J, et al. (2009) Potential impact of viral load and genetic makeup of HIV type 1 on mother-to-child transmission: characterization of env-C2V3C3 and nef sequences. AIDS Res Hum Retroviruses 25: 1171-1177 doi:10.1089/aid.2009.0103.
15. Lawn SD, Butera ST, Folks TM, (2001) Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 14: 753-77, table of contents doi:10.1128/CMR.14.4.753-777.2001.
16. Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, et al. (1991) Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 163: 233-239.
17. Plummer FA, (1998) Heterosexual transmission of human immunodeficiency virus type 1 (HIV): interactions of conventional sexually transmitted diseases, hormonal contraception and HIV-1. AIDS Res Hum Retroviruses 14: S5-10.
18. Corbett EL, Steketee RW, Kuile ter FO, Latif AS, Kamali A, et al. (2002) HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet 359: 2177-2187 doi:10.1016/S0140-6736(02)09095-5.
19. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, et al. (1993) Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7: 95-102.
20. Medzhitov R, Preston-Hurlburt P, Janeway CA, (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397 doi:10.1038/41131.
21. Akira S, Uematsu S, Takeuchi O, (2006) Pathogen recognition and innate immunity. Cell 124: 783-801 doi:10.1016/j.cell.2006.02.015.
22. Dulay AT, Buhimschi CS, Zhao G, Oliver EA, Mbele A, et al. (2009) Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. J Immunol 182: 7244-7253 doi:10.4049/jimmunol.0803517.
23. LeBouder E, Rey-Nores JE, Rushmere NK, Grigorov M, Lawn SD, et al. (2003) Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 171: 6680-6689.
24. LeBouder E, Rey-Nores JE, Raby A-C, Affolter M, Vidal K, et al. (2006) Modulation of neonatal microbial recognition: TLR-mediated innate immune responses are specifically and differentially modulated by human milk. J Immunol 176: 3742-3752.
25. Raby A-C, Le Bouder E, Colmont C, Davies J, Richards P, et al. (2009) Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. J Immunol 183: 506-517 doi:10.4049/jimmunol.0802909.
26. Kuroishi T, Tanaka Y, Sakai A, Sugawara Y, Komine K-I, et al. (2007) Human parotid saliva contains soluble toll-like receptor (TLR) 2 and modulates TLR2-mediated interleukin-8 production by monocytic cells. Mol Immunol 44: 1969-1976 doi:10.1016/j.molimm.2006.09.028.
27. Cario E, Gerken G, Podolsky DK, (2004) Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127: 224-238.
28. Jain S, Rosenthal KL, (2011) The gp41 epitope, QARVLAVERY, is highly conserved and a potent inducer of IgA that neutralizes HIV-1 and inhibits viral transcytosis. Mucosal Immunology pp. 1-15 doi:10.1038/mi.2011.21.
29. Lester RT, Yao X-D, Ball TB, McKinnon LR, Kaul R, et al. (2008) Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 22: 685-694 doi:10.1097/QAD.0b013e3282f4de35.
30. Meng G, (2004) Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J Clin Invest 113: 1473-1481 doi:10.1172/JCI200420762.
31. Brüll F, Mensink RP, van den Hurk K, Duijvestijn A, Plat J, (2010) TLR2 activation is essential to induce a Th1 shift in human peripheral blood mononuclear cells by plant stanols and plant sterols. J Biol Chem 285: 2951-2958 doi:10.1074/jbc.M109.036343.
32. Liew FY, Xu D, Brint EK, O'Neill LAJ, (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5: 446-458 doi:10.1038/nri1630.
33. Greene CM, McElvaney NG, O'Neill SJ, Taggart CC, (2004) Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells. Infect Immun 72: 3684-3687 doi:10.1128/IAI.72.6.3684-3687.2004.
34. Razonable RR, Henault M, Watson HL, Paya CV, (2005) Nystatin induces secretion of interleukin (IL)-1beta, IL-8, and tumor necrosis factor alpha by a toll-like receptor-dependent mechanism. Antimicrob Agents Chemother 49: 3546-3549 doi:10.1128/AAC.49.8.3546-3549.2005.
35. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, et al. (1999) Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163: 1-5.
36. Nilsen NJ, Deininger S, Nonstad U, Skjeldal F, Husebye H, et al. (2008) Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J Leukoc Biol 84: 280-291 doi:10.1189/jlb.0907656.
37. Verhasselt V, (2010) Neonatal tolerance under breastfeeding influence. Curr Opin Immunol 22: 623-630 doi:10.1016/j.coi.2010.08.008.
38. Cario E, Gerken G, Podolsky DK, (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132: 1359-1374 doi:10.1053/j.gastro.2007.02.056.
39. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, et al. (2000) Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164: 966-972.
40. Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, et al. (2002) Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol 76: 8729-8736.
41. Boehme KW, Guerrero M, Compton T, (2006) Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol 177: 7094-7102.
42. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, et al. (2003) Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 77: 4588-4596.
43. Michaud F, Coulombe F, Gaudreault E, Kriz J, Gosselin J, (2010) Involvement of TLR2 in recognition of acute gammaherpesvirus-68 infection. PLoS ONE 5: e13742 doi:10.1371/journal.pone.0013742.
44. Sato A, Linehan MM, Iwasaki A, (2006) Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci USA 103: 17343-17348 doi:10.1073/pnas.0605102103.
45. Weber ANR, Morse MA, Gay NJ, (2004) Four N-linked glycosylation sites in human toll-like receptor 2 cooperate to direct efficient biosynthesis and secretion. J Biol Chem 279: 34589-34594 doi:10.1074/jbc.M403830200.
46. Kataoka H, Yasuda M, Iyori M, Kiura K, Narita M, et al. (2006) Roles of N-linked glycans in the recognition of microbial lipopeptides and lipoproteins by TLR2. Cell Microbiol 8: 1199-1209 doi:10.1111/j.1462-5822.2006.00702.x.
47. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, et al. (2011) Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 108: 4578-4585 doi:10.1073/pnas.1000081107.
48. Heggelund L, Flo T, Berg K, Lien E, Mollnes TE, et al. (2004) Soluble toll-like receptor 2 in HIV infection: association with disease progression. AIDS 18: 2437-2439.
49. Heggelund L, Müller F, Lien E, Yndestad A, Ueland T, et al. (2004) Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin Infect Dis 39: 264-269 doi:10.1086/421780.
50. Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, et al. (2004) Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127: 1513-1524.
51. Neveu D, Viljoen J, Bland RM, Nagot N, Danaviah S, et al. (2011) Cumulative exposure to cell-free HIV in breast milk, rather than feeding pattern per se, identifies postnatally infected infants. Clin Infect Dis 52: 819-825 doi:10.1093/cid/ciq203.
52. Rousseau CM, Nduati RW, Richardson BA, Steele MS, John-Stewart GC, et al. (2003) Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 187: 741-747 doi:10.1086/374273.